Marshall Wace’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-100
Closed -$7.9K – 3252
2025
Q4
$7.9K Buy
+100
New +$7.84K ﹤0.01% 2871
2024
Q1
– Sell
-89,700
Closed -$7.15M – 2478
2023
Q4
$7.15M Buy
+89,700
New +$6.74M 0.01% 783

Other funds holding CL

Marshall Wace's CL Position: Q3 2026 in Review

Marshall Wace sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 163,762 shares — an estimated $15M sold.

Marshall Wace first reported a position in CL in Q1 2014 and held it in 39 quarters. The position peaked at $164M in Q4 2023. 1,946 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Marshall Wace reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Marshall Wace sold 163,762 Colgate-Palmolive shares in Q3 2026, an estimated $15M.
  • Marshall Wace first reported a position in Colgate-Palmolive in Q1 2014 and held it in 39 quarters.
  • Marshall Wace's Colgate-Palmolive position peaked at $164M in Q4 2023.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.